Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
20.23
-6.26 (-23.63%)
At close: Feb 27, 2026, 4:00 PM EST
20.63
+0.40 (1.98%)
After-hours: Feb 27, 2026, 7:56 PM EST
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Amphastar Pharmaceuticals stock have an average target of 30.29, with a low estimate of 25 and a high estimate of 35. The average target predicts an increase of 49.73% from the current stock price of 20.23.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 1 | 1 | 2 |
| Hold | 3 | 3 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $34 → $30 | Buy | Maintains | $34 → $30 | +48.29% | Feb 27, 2026 |
| Needham | Needham | Strong Buy Maintains $34 → $30 | Strong Buy | Maintains | $34 → $30 | +48.29% | Feb 27, 2026 |
| Barclays | Barclays | Hold Initiates $30 | Hold | Initiates | $30 | +48.29% | Dec 9, 2025 |
| Needham | Needham | Strong Buy Maintains $36 → $34 | Strong Buy | Maintains | $36 → $34 | +68.07% | Nov 7, 2025 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +77.95% | Oct 22, 2025 |
Financial Forecast
Revenue This Year
777.47M
from 719.89M
Increased by 8.00%
Revenue Next Year
811.80M
from 777.47M
Increased by 4.42%
EPS This Year
3.71
from 2.03
Increased by 83.00%
EPS Next Year
3.96
from 3.71
Increased by 6.65%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 840.7M | 875.7M | |||
| Avg | 777.5M | 811.8M | |||
| Low | 712.2M | 732.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 16.8% | 12.6% | |||
| Avg | 8.0% | 4.4% | |||
| Low | -1.1% | -5.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.34 | 4.53 | |||
| Avg | 3.71 | 3.96 | |||
| Low | 3.27 | 3.58 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 114.0% | 22.0% | |||
| Avg | 83.0% | 6.7% | |||
| Low | 61.2% | -3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.